HEADER TRANSFERASE 09-AUG-06 2HZI TITLE ABL KINASE DOMAIN IN COMPLEX WITH PD180970 COMPND MOL_ID: 1; COMPND 2 MOLECULE: PROTO-ONCOGENE TYROSINE-PROTEIN KINASE ABL1; COMPND 3 CHAIN: A, B; COMPND 4 SYNONYM: P150, C-ABL, ABELSON MURINE LEUKEMIA VIRAL ONCOGENE HOMOLOG COMPND 5 1; COMPND 6 EC: 2.7.10.2; COMPND 7 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: ABL1; SOURCE 6 EXPRESSION_SYSTEM: SPODOPTERA FRUGIPERDA; SOURCE 7 EXPRESSION_SYSTEM_COMMON: FALL ARMYWORM; SOURCE 8 EXPRESSION_SYSTEM_TAXID: 7108 KEYWDS TYROSINE KINASE, TRANSFERASE EXPDTA X-RAY DIFFRACTION AUTHOR S.W.COWAN-JACOB,G.FENDRICH,J.LIEBETANZ,D.FABBRO,P.MANLEY REVDAT 3 21-FEB-24 2HZI 1 REMARK SEQADV REVDAT 2 24-FEB-09 2HZI 1 VERSN REVDAT 1 16-JAN-07 2HZI 0 JRNL AUTH S.W.COWAN-JACOB,G.FENDRICH,A.FLOERSHEIMER,P.FURET, JRNL AUTH 2 J.LIEBETANZ,G.RUMMEL,P.RHEINBERGER,M.CENTELEGHE,D.FABBRO, JRNL AUTH 3 P.W.MANLEY JRNL TITL STRUCTURAL BIOLOGY CONTRIBUTIONS TO THE DISCOVERY OF DRUGS JRNL TITL 2 TO TREAT CHRONIC MYELOGENOUS LEUKAEMIA. JRNL REF ACTA CRYSTALLOGR.,SECT.D V. 63 80 2007 JRNL REFN ISSN 0907-4449 JRNL PMID 17164530 JRNL DOI 10.1107/S0907444906047287 REMARK 2 REMARK 2 RESOLUTION. 1.70 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.0 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.70 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 81.65 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : NULL REMARK 3 NUMBER OF REFLECTIONS : 83093 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.177 REMARK 3 R VALUE (WORKING SET) : 0.176 REMARK 3 FREE R VALUE : 0.204 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 4365 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 1.70 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 1.74 REMARK 3 REFLECTION IN BIN (WORKING SET) : 6124 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 BIN R VALUE (WORKING SET) : 0.2290 REMARK 3 BIN FREE R VALUE SET COUNT : 308 REMARK 3 BIN FREE R VALUE : 0.2620 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 4274 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 58 REMARK 3 SOLVENT ATOMS : 540 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 21.21 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 0.64000 REMARK 3 B22 (A**2) : 0.15000 REMARK 3 B33 (A**2) : -0.79000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.085 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.086 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.081 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 2.435 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.961 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.947 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 4506 ; 0.018 ; 0.022 REMARK 3 BOND LENGTHS OTHERS (A): 3962 ; 0.001 ; 0.020 REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 6128 ; 1.685 ; 1.961 REMARK 3 BOND ANGLES OTHERS (DEGREES): 9213 ; 1.374 ; 3.000 REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 542 ; 4.882 ; 3.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): NULL ; NULL ; NULL REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 811 ;14.586 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): NULL ; NULL ; NULL REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 643 ; 0.100 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 4979 ; 0.007 ; 0.020 REMARK 3 GENERAL PLANES OTHERS (A): 921 ; 0.003 ; 0.020 REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): 976 ; 0.230 ; 0.300 REMARK 3 NON-BONDED CONTACTS OTHERS (A): 3790 ; 0.197 ; 0.300 REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): 5 ; 0.097 ; 0.500 REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): 500 ; 0.165 ; 0.500 REMARK 3 H-BOND (X...Y) OTHERS (A): 2 ; 0.166 ; 0.500 REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): 7 ; 0.281 ; 0.300 REMARK 3 SYMMETRY VDW OTHERS (A): 32 ; 0.195 ; 0.300 REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): 26 ; 0.204 ; 0.500 REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 2673 ; 0.985 ; 1.500 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 4326 ; 1.785 ; 2.000 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 1833 ; 2.823 ; 3.000 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): 1802 ; 4.464 ; 4.500 REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : BABINET MODEL WITH MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.40 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS REMARK 4 REMARK 4 2HZI COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 10-AUG-06. REMARK 100 THE DEPOSITION ID IS D_1000038947. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 15-JUN-01 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ESRF REMARK 200 BEAMLINE : ID14-1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.934 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : MAR CCD 165 MM REMARK 200 INTENSITY-INTEGRATION SOFTWARE : MOSFLM REMARK 200 DATA SCALING SOFTWARE : SCALA, CCP4 (SCALA) REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 87524 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.700 REMARK 200 RESOLUTION RANGE LOW (A) : 82.758 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.5 REMARK 200 DATA REDUNDANCY : 4.800 REMARK 200 R MERGE (I) : 0.07000 REMARK 200 R SYM (I) : 0.07000 REMARK 200 FOR THE DATA SET : 8.3000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.70 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.79 REMARK 200 COMPLETENESS FOR SHELL (%) : 100.0 REMARK 200 DATA REDUNDANCY IN SHELL : 4.90 REMARK 200 R MERGE FOR SHELL (I) : 0.42400 REMARK 200 R SYM FOR SHELL (I) : 0.42400 REMARK 200 FOR SHELL : 1.700 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: FOURIER SYNTHESIS REMARK 200 SOFTWARE USED: NULL REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 60.10 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 3.08 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.9 M NAACETATE, 0.1 M NACACODYLATE PH REMARK 280 7.0, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 277K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z REMARK 290 3555 -X+1/2,Y+1/2,-Z REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 53.23750 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 65.76650 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 53.23750 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 65.76650 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 224 REMARK 465 ALA A 225 REMARK 465 MET A 226 REMARK 465 ASP A 227 REMARK 465 PRO A 228 REMARK 465 SER A 229 REMARK 465 PRO A 230 REMARK 465 ASN A 231 REMARK 465 TYR A 232 REMARK 465 GLY B 224 REMARK 465 ALA B 225 REMARK 465 MET B 226 REMARK 465 ASP B 227 REMARK 465 PRO B 228 REMARK 465 SER B 229 REMARK 465 PRO B 230 REMARK 465 ASN B 231 REMARK 465 TYR B 232 REMARK 465 LYS B 274 REMARK 465 GLU B 275 REMARK 465 ASP B 276 REMARK 465 THR B 277 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 LYS A 234 NZ REMARK 470 LYS A 247 NZ REMARK 470 ARG A 307 CD NE CZ NH1 NH2 REMARK 470 GLU A 308 CG CD OE1 OE2 REMARK 470 LYS A 356 CE NZ REMARK 470 LYS A 400 CD CE NZ REMARK 470 GLU A 466 CD OE1 OE2 REMARK 470 LYS A 467 NZ REMARK 470 LYS B 234 NZ REMARK 470 GLU B 238 CD OE1 OE2 REMARK 470 ARG B 239 NE CZ NH1 NH2 REMARK 470 LYS B 245 CE NZ REMARK 470 LYS B 247 NZ REMARK 470 LYS B 262 NZ REMARK 470 LYS B 263 CE NZ REMARK 470 GLU B 279 OE1 OE2 REMARK 470 GLU B 281 CG CD OE1 OE2 REMARK 470 GLU B 282 CD OE1 OE2 REMARK 470 ARG B 307 NE CZ NH1 NH2 REMARK 470 GLU B 308 CG CD OE1 OE2 REMARK 470 LYS B 400 CG CD CE NZ REMARK 470 GLU B 462 CG CD OE1 OE2 REMARK 470 GLU B 466 CD OE1 OE2 REMARK 470 LYS B 467 NZ REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 OD1 ASN A 479 O HOH A 770 2.10 REMARK 500 O HOH A 777 O HOH B 727 2.13 REMARK 500 O LEU B 273 O HOH B 804 2.18 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 ASP B 233 CB - CG - OD2 ANGL. DEV. = 5.7 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 LYS A 245 -122.50 -111.06 REMARK 500 ARG A 362 -4.50 74.37 REMARK 500 ASP A 363 45.32 -144.89 REMARK 500 LEU A 387 117.93 -160.44 REMARK 500 TYR A 440 59.98 38.53 REMARK 500 LYS B 234 -15.12 -47.17 REMARK 500 ARG B 239 -37.90 -38.40 REMARK 500 LYS B 245 -129.30 -124.37 REMARK 500 GLU B 279 6.68 -62.40 REMARK 500 ARG B 362 -2.92 76.53 REMARK 500 ASP B 363 48.34 -144.58 REMARK 500 THR B 389 -79.11 -130.59 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE JIN A 600 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE JIN B 600 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 2HYY RELATED DB: PDB REMARK 900 RELATED ID: 2HZ0 RELATED DB: PDB REMARK 900 RELATED ID: 2HZ4 RELATED DB: PDB DBREF 2HZI A 229 500 UNP P00519 ABL1_HUMAN 229 500 DBREF 2HZI B 229 500 UNP P00519 ABL1_HUMAN 229 500 SEQADV 2HZI GLY A 224 UNP P00519 CLONING ARTIFACT SEQADV 2HZI ALA A 225 UNP P00519 CLONING ARTIFACT SEQADV 2HZI MET A 226 UNP P00519 CLONING ARTIFACT SEQADV 2HZI ASP A 227 UNP P00519 CLONING ARTIFACT SEQADV 2HZI PRO A 228 UNP P00519 CLONING ARTIFACT SEQADV 2HZI GLY B 224 UNP P00519 CLONING ARTIFACT SEQADV 2HZI ALA B 225 UNP P00519 CLONING ARTIFACT SEQADV 2HZI MET B 226 UNP P00519 CLONING ARTIFACT SEQADV 2HZI ASP B 227 UNP P00519 CLONING ARTIFACT SEQADV 2HZI PRO B 228 UNP P00519 CLONING ARTIFACT SEQRES 1 A 277 GLY ALA MET ASP PRO SER PRO ASN TYR ASP LYS TRP GLU SEQRES 2 A 277 MET GLU ARG THR ASP ILE THR MET LYS HIS LYS LEU GLY SEQRES 3 A 277 GLY GLY GLN TYR GLY GLU VAL TYR GLU GLY VAL TRP LYS SEQRES 4 A 277 LYS TYR SER LEU THR VAL ALA VAL LYS THR LEU LYS GLU SEQRES 5 A 277 ASP THR MET GLU VAL GLU GLU PHE LEU LYS GLU ALA ALA SEQRES 6 A 277 VAL MET LYS GLU ILE LYS HIS PRO ASN LEU VAL GLN LEU SEQRES 7 A 277 LEU GLY VAL CYS THR ARG GLU PRO PRO PHE TYR ILE ILE SEQRES 8 A 277 THR GLU PHE MET THR TYR GLY ASN LEU LEU ASP TYR LEU SEQRES 9 A 277 ARG GLU CYS ASN ARG GLN GLU VAL ASN ALA VAL VAL LEU SEQRES 10 A 277 LEU TYR MET ALA THR GLN ILE SER SER ALA MET GLU TYR SEQRES 11 A 277 LEU GLU LYS LYS ASN PHE ILE HIS ARG ASP LEU ALA ALA SEQRES 12 A 277 ARG ASN CYS LEU VAL GLY GLU ASN HIS LEU VAL LYS VAL SEQRES 13 A 277 ALA ASP PHE GLY LEU SER ARG LEU MET THR GLY ASP THR SEQRES 14 A 277 TYR THR ALA HIS ALA GLY ALA LYS PHE PRO ILE LYS TRP SEQRES 15 A 277 THR ALA PRO GLU SER LEU ALA TYR ASN LYS PHE SER ILE SEQRES 16 A 277 LYS SER ASP VAL TRP ALA PHE GLY VAL LEU LEU TRP GLU SEQRES 17 A 277 ILE ALA THR TYR GLY MET SER PRO TYR PRO GLY ILE ASP SEQRES 18 A 277 LEU SER GLN VAL TYR GLU LEU LEU GLU LYS ASP TYR ARG SEQRES 19 A 277 MET GLU ARG PRO GLU GLY CYS PRO GLU LYS VAL TYR GLU SEQRES 20 A 277 LEU MET ARG ALA CYS TRP GLN TRP ASN PRO SER ASP ARG SEQRES 21 A 277 PRO SER PHE ALA GLU ILE HIS GLN ALA PHE GLU THR MET SEQRES 22 A 277 PHE GLN GLU SER SEQRES 1 B 277 GLY ALA MET ASP PRO SER PRO ASN TYR ASP LYS TRP GLU SEQRES 2 B 277 MET GLU ARG THR ASP ILE THR MET LYS HIS LYS LEU GLY SEQRES 3 B 277 GLY GLY GLN TYR GLY GLU VAL TYR GLU GLY VAL TRP LYS SEQRES 4 B 277 LYS TYR SER LEU THR VAL ALA VAL LYS THR LEU LYS GLU SEQRES 5 B 277 ASP THR MET GLU VAL GLU GLU PHE LEU LYS GLU ALA ALA SEQRES 6 B 277 VAL MET LYS GLU ILE LYS HIS PRO ASN LEU VAL GLN LEU SEQRES 7 B 277 LEU GLY VAL CYS THR ARG GLU PRO PRO PHE TYR ILE ILE SEQRES 8 B 277 THR GLU PHE MET THR TYR GLY ASN LEU LEU ASP TYR LEU SEQRES 9 B 277 ARG GLU CYS ASN ARG GLN GLU VAL ASN ALA VAL VAL LEU SEQRES 10 B 277 LEU TYR MET ALA THR GLN ILE SER SER ALA MET GLU TYR SEQRES 11 B 277 LEU GLU LYS LYS ASN PHE ILE HIS ARG ASP LEU ALA ALA SEQRES 12 B 277 ARG ASN CYS LEU VAL GLY GLU ASN HIS LEU VAL LYS VAL SEQRES 13 B 277 ALA ASP PHE GLY LEU SER ARG LEU MET THR GLY ASP THR SEQRES 14 B 277 TYR THR ALA HIS ALA GLY ALA LYS PHE PRO ILE LYS TRP SEQRES 15 B 277 THR ALA PRO GLU SER LEU ALA TYR ASN LYS PHE SER ILE SEQRES 16 B 277 LYS SER ASP VAL TRP ALA PHE GLY VAL LEU LEU TRP GLU SEQRES 17 B 277 ILE ALA THR TYR GLY MET SER PRO TYR PRO GLY ILE ASP SEQRES 18 B 277 LEU SER GLN VAL TYR GLU LEU LEU GLU LYS ASP TYR ARG SEQRES 19 B 277 MET GLU ARG PRO GLU GLY CYS PRO GLU LYS VAL TYR GLU SEQRES 20 B 277 LEU MET ARG ALA CYS TRP GLN TRP ASN PRO SER ASP ARG SEQRES 21 B 277 PRO SER PHE ALA GLU ILE HIS GLN ALA PHE GLU THR MET SEQRES 22 B 277 PHE GLN GLU SER HET JIN A 600 29 HET JIN B 600 29 HETNAM JIN 6-(2,6-DICHLOROPHENYL)-2-[(4-FLUORO-3-METHYLPHENYL) HETNAM 2 JIN AMINO]-8-METHYLPYRIDO[2,3-D]PYRIMIDIN-7(8H)-ONE HETSYN JIN PD180970 FORMUL 3 JIN 2(C21 H15 CL2 F N4 O) FORMUL 5 HOH *540(H2 O) HELIX 1 1 GLU A 238 THR A 240 5 3 HELIX 2 2 GLY A 249 GLN A 252 5 4 HELIX 3 3 LYS A 263 SER A 265 5 3 HELIX 4 4 GLU A 279 LYS A 291 1 13 HELIX 5 5 LEU A 323 CYS A 330 1 8 HELIX 6 6 ASN A 336 LYS A 357 1 22 HELIX 7 7 ALA A 365 ARG A 367 5 3 HELIX 8 8 GLU A 373 HIS A 375 5 3 HELIX 9 9 PRO A 402 THR A 406 5 5 HELIX 10 10 ALA A 407 ASN A 414 1 8 HELIX 11 11 SER A 417 THR A 434 1 18 HELIX 12 12 ASP A 444 SER A 446 5 3 HELIX 13 13 GLN A 447 LYS A 454 1 8 HELIX 14 14 PRO A 465 TRP A 476 1 12 HELIX 15 15 ASN A 479 ARG A 483 5 5 HELIX 16 16 SER A 485 SER A 500 1 16 HELIX 17 17 GLU B 238 THR B 240 5 3 HELIX 18 18 GLY B 249 GLN B 252 5 4 HELIX 19 19 GLU B 279 ILE B 293 1 15 HELIX 20 20 ASN B 322 CYS B 330 1 9 HELIX 21 21 ASN B 336 LYS B 357 1 22 HELIX 22 22 ALA B 365 ARG B 367 5 3 HELIX 23 23 GLU B 373 HIS B 375 5 3 HELIX 24 24 PRO B 402 THR B 406 5 5 HELIX 25 25 ALA B 407 ASN B 414 1 8 HELIX 26 26 SER B 417 THR B 434 1 18 HELIX 27 27 ASP B 444 SER B 446 5 3 HELIX 28 28 GLN B 447 LYS B 454 1 8 HELIX 29 29 PRO B 465 TRP B 476 1 12 HELIX 30 30 ASN B 479 ARG B 483 5 5 HELIX 31 31 SER B 485 SER B 500 1 16 SHEET 1 A 5 ILE A 242 LYS A 247 0 SHEET 2 A 5 VAL A 256 TRP A 261 -1 O GLU A 258 N LYS A 245 SHEET 3 A 5 LEU A 266 THR A 272 -1 O LEU A 266 N TRP A 261 SHEET 4 A 5 TYR A 312 GLU A 316 -1 O ILE A 313 N LYS A 271 SHEET 5 A 5 LEU A 301 CYS A 305 -1 N LEU A 302 O ILE A 314 SHEET 1 B 3 GLY A 321 ASN A 322 0 SHEET 2 B 3 CYS A 369 VAL A 371 -1 O VAL A 371 N GLY A 321 SHEET 3 B 3 VAL A 377 VAL A 379 -1 O LYS A 378 N LEU A 370 SHEET 1 C 2 PHE A 359 ILE A 360 0 SHEET 2 C 2 SER A 385 ARG A 386 -1 O SER A 385 N ILE A 360 SHEET 1 D 2 TYR A 393 THR A 394 0 SHEET 2 D 2 LYS A 415 PHE A 416 -1 O PHE A 416 N TYR A 393 SHEET 1 E 5 ILE B 242 LYS B 247 0 SHEET 2 E 5 VAL B 256 TRP B 261 -1 O GLU B 258 N HIS B 246 SHEET 3 E 5 LEU B 266 THR B 272 -1 O VAL B 270 N TYR B 257 SHEET 4 E 5 TYR B 312 GLU B 316 -1 O THR B 315 N ALA B 269 SHEET 5 E 5 LEU B 301 CYS B 305 -1 N LEU B 302 O ILE B 314 SHEET 1 F 2 PHE B 359 ILE B 360 0 SHEET 2 F 2 SER B 385 ARG B 386 -1 O SER B 385 N ILE B 360 SHEET 1 G 2 CYS B 369 VAL B 371 0 SHEET 2 G 2 VAL B 377 VAL B 379 -1 O LYS B 378 N LEU B 370 SHEET 1 H 2 TYR B 393 THR B 394 0 SHEET 2 H 2 LYS B 415 PHE B 416 -1 O PHE B 416 N TYR B 393 CISPEP 1 PRO A 309 PRO A 310 0 -2.07 CISPEP 2 PRO B 309 PRO B 310 0 4.84 SITE 1 AC1 16 TYR A 253 VAL A 256 ALA A 269 LYS A 271 SITE 2 AC1 16 MET A 290 THR A 315 GLU A 316 MET A 318 SITE 3 AC1 16 TYR A 320 GLY A 321 LEU A 370 ALA A 380 SITE 4 AC1 16 ASP A 381 HOH A 774 HOH A 793 HOH A 831 SITE 1 AC2 12 TYR B 253 ALA B 269 LYS B 271 MET B 290 SITE 2 AC2 12 THR B 315 GLU B 316 MET B 318 GLY B 321 SITE 3 AC2 12 LEU B 370 ALA B 380 ASP B 381 PHE B 382 CRYST1 106.475 131.533 56.459 90.00 90.00 90.00 P 21 21 2 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.009392 0.000000 0.000000 0.00000 SCALE2 0.000000 0.007603 0.000000 0.00000 SCALE3 0.000000 0.000000 0.017712 0.00000